Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI – a prospective multinational study - Poll - MDSpire

Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI – a prospective multinational study

  • By

  • Aske Foldbjerg Laustsen

  • Jonathan Kjær Grønbæk

  • Radek Frič

  • Shivaram Avula

  • Conor Mallucci

  • Pelle Nilsson

  • Per Nyman

  • Péter Hauser

  • Katalin Mudra

  • Rosita Kiudeliene

  • Saulius Ročka

  • Magnus Aasved Hjort

  • Rick Brandsma

  • Eelco Hoving

  • Andrea Carai

  • Vladimír Beneš

  • Jana Táborská

  • Christian Dorfer

  • Sandra Jacobs

  • Miriam Pavon-Mengual

  • Jane Skjøth-Rasmussen

  • Kjeld Schmiegelow

  • Astrid Sehested

  • René Mathiasen

  • Marianne Juhler

  • September 22, 2025

  • 0 min

Share

Original Source(s)

Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI – a prospective multinational study

  • by Aske Foldbjerg Laustsen, Jonathan Kjær Grønbæk, Radek Frič, Shivaram Avula, Conor Mallucci, Pelle Nilsson, Per Nyman, Péter Hauser, Katalin Mudra, Rosita Kiudeliene, Saulius Ročka, Magnus Aasved Hjort, Rick Brandsma, Eelco Hoving, Andrea Carai, Vladimír Beneš, Jana Táborská, Christian Dorfer, Sandra Jacobs, Miriam Pavon-Mengual, Jane Skjøth-Rasmussen, Kjeld Schmiegelow, Astrid Sehested, René Mathiasen, Marianne Juhler

  • September 22, 2025

Related Content

The awakening effect of hyperbaric oxygen therapy combined with systematic auditory stimulation in comatose patients with craniocerebral injury and its influence on serum biomarkers

Comparative outcomes of robotic single-port vNOTES versus robotic-Xi assisted single-incision transumbilical surgery for hysterectomy

Postop Pain Differs by Vitamin D Status

Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.